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Background: The aim of the present study was to assess the relationship between changes in NT-proBNP after CRT and clinical and 
echocardiographic response in heart failure patients.
Methods: 170 patients treated with CRT were included (mean age 61 ± 11 years, 75% male, QRS duration 154 ± 30 ms). Clinical and 
echocardiographic parameters and circulating NT-proBNP levels were assessed at baseline and 6 months after CRT. At 6 months follow-up, increase 
in New York Heart Association class ≥ 1 point, decrease in left ventricular end-systolic volume ≥ 15% and decrease in NT-proBNP ≥ 15% defined 
clinical, echocardiographic and neurohormonal CRT response, respectively. All-cause mortality data were also collected.
Results: At 6 months follow-up, percentages of neurohormonal, echocardiographic and clinical response were 54%, 58% and 66%, respectively. 
Majority of patients (71%) who showed echocardiographic response had a reduction in NT-proBNP ≥ 15%. In contrast, only 58% of patients who 
showed clinical response had also significant NT-proBNP reduction. Patients with neurohormonal response to CRT demonstrated a significantly better 
long-term outcome compared to patients without neurohormonal response (log-rank P = 0.02, Figure).
Conclusions: NT-proBNP reduction showed a better agreement with echocardiographic response compared to clinical response, indicating that 
echocardiographic response and NT-proBNP may be more useful to evaluate the effects of CRT.
 
